HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Saiko Hosokawa Selected Research

MCC465

7/2004Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Saiko Hosokawa Research Topics

Disease

4Neoplasms (Cancer)
05/2008 - 04/2004
1Lung Neoplasms (Lung Cancer)
11/2005
1Colorectal Neoplasms (Colorectal Cancer)
07/2004
1Breast Neoplasms (Breast Cancer)
07/2004

Drug/Important Bio-Agent (IBA)

5Monoclonal AntibodiesIBA
05/2008 - 04/2004
1StreptavidinIBA
05/2008
1Coloring Agents (Dyes)IBA
10/2004
1Chlorophyll AIBA
10/2004
1peridininIBA
10/2004
1Proteins (Proteins, Gene)FDA Link
10/2004
1EpitopesIBA
07/2004
1liposomal doxorubicin (Doxil)FDA Link
07/2004
1MCC465IBA
07/2004
1AntibodiesIBA
04/2004
1Liposomes (Liposome)IBA
04/2004

Therapy/Procedure

1Quantum Dots (Quantum Dot)
05/2008
1Therapeutics
05/2008
1Drug Therapy (Chemotherapy)
04/2004